Company News
-
How Can Freeze-Drying Technology Make Molecular Diagnostics More Stable, Cost-Effective, Simple, and Convenient? Macro & Micro-Test(MMT) Has the Innovative Answer!
As nucleic acid testing becomes a routine necessity, have you faced these challenges: reagents that risk degradation during transport, contamination-prone opening procedures, or activity loss from repeated freeze-thaw cycles? A century-old “age-defying” technology—vacuum freeze-drying...Read more -
From Vague Threat to Clear Action: Redefining the Standard with HPV 28 Genotyping
Human papillomavirus (HPV) infections are extremely common. While the majority of infections are cleared by the immune system within 1-2 years without consequence, a small percentage of persistent high-risk HPV infections can silently initiate a carcinogenic process that may span 10 to 20 years. ...Read more -
Fully Automation Molecular POCT and NGS For Diarrhea Detection
Diarrhea is often a sign of gastrointestinal infection caused by viruses, bacteria, or other pathogens. It poses significant risks not only to children but also to the elderly, immunocompromised individuals, and people in crowded or post-disaster settings. Particularly during the autumn and winte...Read more -
Transforming C. diff Detection: Achieving Fully Automated, Sample-to-Answer Molecular Diagnostics
What causes C. Diff infection? Diff infection is caused by a bacterium known as Clostridioides difficile (C. difficile), that usually resides harmlessly in the intestines. However, when the gut’s bacterial balance is disturbed, often broad-spectrum antibiotic use, C. difficile can grow excessive...Read more -
Beyond the Common Cold: Understanding the True Impact of Human Metapneumovirus (hMPV)
When a child develops a runny nose, cough, or fever, many parents instinctively think of the common cold or flu. Yet a significant share of these respiratory illnesses—especially the more severe ones—are caused by a lesser-known pathogen: Human Metapneumovirus (hMPV). Since its discovery in 2001,...Read more -
From Silent Infection to Preventable Tragedy: Break the Chain with Sample-to-Answer HR-HPV Screening
This moment matters. Every life counts. Under the global call to “Act Now: Eliminate Cervical Cancer,” the world is accelerating toward the 90-70-90 targets by 2030: -90% of girls vaccinated against HPV by age 15 -70% of women screened with a high-performance test by ages 35 and 45 -90% of women ...Read more -
The Silent Pandemic Amplifying TB’s Threat: AMR Crisis Looms
The #WHO’s latest tuberculosis report reveals a stark reality: 8.2 million new TB cases were diagnosed in 2023—the highest since global monitoring began in 1995. This surge from 7.5 million in 2022 reinstates TB as the leading infectious disease killer, surpassing COVID-19. Yet, an even graver cr...Read more -
The Critical Role of Biomarker Testing in Top Cancer Killer
According to the latest global cancer report, lung cancer continues to be the foremost cause of cancer-related deaths worldwide, accounting for 18.7% of all such fatalities in 2022. The vast majority of these cases are Non-Small Cell Lung Cancer (NSCLC). While the historical reliance on chemother...Read more -
Understanding HPV and the Power of HPV 28 Typing Detection
What is HPV? Human Papillomavirus (HPV) is one of the most common sexually transmitted infections (STIs) globally. It’s a group of more than 200 related viruses, and about 40 of them can infect the genital area, mouth, or throat. Some HPV types are harmless, while others can cause serious h...Read more -
Stay Ahead of Respiratory Infections: Cutting-Edge Multiplex Diagnostics for Rapid and Accurate Solutions
As the autumn and winter seasons arrive, bringing a sharp drop in temperatures, we enter a period of high incidence for respiratory infections—a persistent and formidable challenge to global public health. These infections range from the frequent colds that trouble young children to severe pneumo...Read more -
Targeting NSCLC: Key Biomarkers Revealed
Lung cancer remains a leading cause of cancer-related mortality worldwide, with Non-Small Cell Lung Cancer (NSCLC) accounting for approximately 85% of all cases. For decades, the treatment of advanced NSCLC relied primarily on chemotherapy, a blunt instrument that offered limited efficacy and sig...Read more -
Precision Management of CML: The Critical Role of BCR-ABL Detection in the TKI Era
Chronic Myelogenous Leukemia (CML) management has been revolutionized by Tyrosine Kinase Inhibitors (TKIs), turning a once-fatal disease into a manageable chronic condition. At the heart of this success story lies precise and reliable monitoring of the BCR-ABL fusion gene—the definitive molecular...Read more